World Mycoplasma Diagnostics Market 2017-2021 - Emerging Opportunities and Growth Strategies - Research and Markets

DUBLIN--()--The "2017-2021 World Mycoplasma Diagnostics Market: Emerging Opportunities and Growth Strategies" report has been added to Research and Markets' offering.

The report presents a detailed analysis of the Mycoplasma diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Mycoplasma definition, epidemiology and etiology are reviewed.

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Mycoplasma tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

The report provides the 5-year test volume and sales forecasts by country for the following market segments:

  • Hospitals
  • Commercial/Private Labs
  • Physician Offices
  • Public Health Labs

Key Topics Covered:

I. Introduction

II. Worldwide Test Overview,

Technologies and Instrumentation

A. Background, Diagnostic Tests, Vaccines and Drugs

B. Instrumentation Review: Operating Characteristics,

Features and Selling Princes of Leading Infectious Disease

Automated and Semi-automated Analyzers

C. Emerging Infectious Disease Diagnostic Technologies

1. Molecular Diagnostics

2. Monoclonal Antibodies

3. Immunoassays

4. Differential Light Scattering

5. Information Technology

6. Artificial Intelligence

7. Liposomes

8. Flow Cytometry

9. Chromatography

10. Diagnostic Imaging

11. Gel Microdroplets

12. Others

D. Personal Testing

III. Country Analyses: Sales and Volume Forecasts

IV. Major Product Development Opportunities

A. Instrumentation

B. Reagent Kits and Test Systems/Panels

C. Information Technology

D. Auxiliary Products

V. Design Criteria for Decentralized Testing Products

VI. Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for Decentralized Testing Markets

VII. Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

VIII. Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix/Erba
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech/Leica
  • Lonza
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher/Life Technology
  • Wallac/PE
  • Wako

For more information about this report visit https://www.researchandmarkets.com/research/m6pd55/20172021_world

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing